Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 551-560 of 2932 for cancer

Edit search filters
  1. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  2. Nurse-Led Acupressure Intervention For Patients Receiving Chemotherapy

    Rochester, MN

  3. Methotrexate, Erlotinib, And Celecoxib For The Treatment Of Recurrent/Metastatic Oral Cavity Cancer In A Rural Midwest United States Population

    Albert Lea, MN, La Crosse, WI, Rochester, MN

  4. Vaccine Therapy In Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, Or Primary Peritoneal Cavity Cancer Following Surgery And Chemotherapy

    Rochester, MN

  5. A Master Protocol To Evaluate The Long-Term Safety Of (LY3527727) Pirtobrutinib

    Rochester, MN

  6. A Trial Of Casdozokitug In Combination With Toripalimab Plus Bevacizumab In Participants With Unresectable And/or Locally Advanced Or Metastatic Hepatocellular Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. A Study Of Nivolumab In Participants With Metastatic Or Unresectable Bladder Cancer

    Scottsdale/Phoenix, AZ

  8. A Study Of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy For Advanced Non-Small Cell Lung Cancer (MK-3475-495)

    Jacksonville, FL, Rochester, MN

  9. A Study Of SGN-B7H4V In Advanced Solid Tumors

    Jacksonville, FL

  10. A Feasibility Study To Evaluate The Safety Of The TheraSphere Glioblastoma (GBM) Device In Patients With Recurrent GBM

    Jacksonville, FL

.

Mayo Clinic Footer